StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) stock

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 12/30104% above fair value
$170.26+2.68 (+1.60%)

Close on Nov 17, 2026Market cap $211.18BP/E –Yield 1.86%

Gilead Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Gilead Sciences's market cap was $210.63B on Nov 11, 2026, against $156.29B a year earlier. Over the last 5 years it ranged from $74.41B to $211.81B, with a median of $104.46B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$210.63B+38.2%
2025Dec 31, 2025$152.44B+32.5%
2024Dec 31, 2024$115.09B+13.9%
2023Dec 29, 2023$101.02B-6.2%
2022Dec 30, 2022$107.66B+18.1%
2021Dec 31, 2021$91.13B+24.8%
2020Dec 31, 2020$73.00B-11.3%
2019Dec 31, 2019$82.26B+1.6%
2018Dec 31, 2018$80.94B-13.6%
2017Dec 29, 2017$93.63B-1.1%
2016Dec 30, 2016$94.67B-35.4%
2015Dec 31, 2015$146.62B+2.8%
2014Dec 31, 2014$142.67B+23.8%
2013Dec 31, 2013$115.21B+106.9%
2012Dec 31, 2012$55.67B+79.9%
2011Dec 30, 2011$30.95B+4.7%
2010Dec 31, 2010$29.55B-24.3%
2009Dec 31, 2009$39.02B–

More Gilead Sciences figures

See a number that looks wrong?